ChIPSeeker: an R/Bioconductor package for the annotation and comparison of ChIP peak annotations and visualization in mesodermal cells
Yu, G., Wang, L.-G. & He, Q.-Y. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2385–2383.
Perovanovic, J. et al. Oct1 cooperates with the Smad family of transcription factors to promote mesodermal lineage specification. A signal in the science of signal.
Farashidfar, F. A correlation between focal amplification of 22q11.21 and metastasis is found in acral melanoma. Nat. Commun. 13, 898 (2022).
Soule, H. D., Vazguez, J., Long, A., Albert, S. & Brennan, M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl Cancer Inst. 51, 1409–1416 (1973).
Source: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin
Galaxy: a community of microarray data scientists with applications to genetics, cellular genetics and gene expression studies of sex hormone-dependent cancer
Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118–127 (2007).
Motakis, E. S., Nason, G. P., Fryzlewicz, P. & Rutter, G. A. Variance stabilization and normalization for one-color microarray data using a data-driven multiscale approach. Bioinformatics 22, 2547–2553 (2006).
The Galaxy Community. The Galaxy platform for accessible, reproducible and collaborative medical analyses is up to date. A list of the acids contained in the Nucleic Acids Res. 50.
Langmead, B., Wilks, C., Antonescu, V. & Charles, R. Scaling read aligners to hundreds of threads on general-purpose processors. 35, 423–432 were published in 2019.
Source: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin
Activated promoter networks control self-renewal and commitment of nephron progenitors through a whole-genome estrogen receptor binding network
S C. et al. The research uses whole-genome estrogen receptor binding in mouse uterine tissue. Mol. The article was titled “Endocrinol. 26, 887–898”
Park, J.-S. et al. Six2 and Wnt regulate self-renewal and commitment of nephron progenitors through shared gene regulatory networks. Dev. Cell 23, 637–651 (2012).
Rhie, S. K. et al. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits. Epigenetics Chromatin 9, 50 (2016).
Nair, S. J. et al. There is phase separation of enhancers. Nat. Struct. Mol. Biol. 26, 193–203 (2019).
Estarás, C., Benner, C. & Jones, K. A. SMADs and YAP compete to control elongation of β-catenin:LEF-1-recruited RNAPII during hESC differentiation. Mol. Cell 58, 780–793 (2015).
Source: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin
Digital gene expression data analysis of mouse’s melanoma cell lines: p16INK4a/cenin and -Catenin induced immortalization
Petit, V. In the lab and in the real world, C57BL/6 congenic mouse’s melanoma cell lines are very sensitive to the combinations of Mek and Akt. Pigment Cell Melanoma Res. 32, 829–841 (2019).
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).
Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882–883 (2012).
The skin melanocytes are disrupted in Cre-mediated recombination. Genesis 36, 73–80 (2003).
The E-cadherin/catenin complex plays an important role in breast cancer. Breast Cancer Res. 3, 289–293 (2001).
DelMas, V and others. β-Catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev. 21, 2923–2935 (2007).
Source: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin
YAP/TAZ-TEAD interaction modulated by palmitoylation and small-molecule inhibitors: A study of the Hippo pathway in human cancers
J. L. V. Agostino, An R package for visualization of anatograms and tissues based on ggplot2. F 1000 research, published in the journal F 1000 Research, on09.1642
The YAP/TAZ-TEAD interaction was allosteric modulation by palmitoylation and small-molecule inhibitors. J.phys. There is a Chem. B 128, 3795–3806 (2024).
A study on the cause of human cancers and the effects of Hippo pathway components. There is a front. Cell phone number Biol. 9, 661718 (2021).
Source: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin
Human Gastrin – Receptor- Induced Treatment of Sex hormone-dependent Cancer: A Phase I Trial of a Novel Bombesin/Gastrin-Rereleasing Peptide (RC3095)
S. et al. Human gastrin-releasing peptide Receptor bound to agonist and antagonist for cancer and itch therapy has structures. Proc. The Natl Acad. is a branch of the sciences. USA 120, also known as e2 2210 120.
L. L. et al. Bombesin-triggered feeding suppression was lost in the gastrin-releasing peptide receptor- deficient mice. Proc. National Acad. The USA 95 was published in 1998.
Schwartsmann, et al. A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies. Invest. New Drugs 24, 403–412 (2006).
Source: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin
Analgesic effect of gastrin-releasing peptide in the dorsal horn of sex hormone-dependent cancer
Polgr, E. Grpr expression defines a population of superficial dorsal horn vertical cells that have a role in both itch and pain. Pain 169, 169, 169, 169, 169.
Saeki, A., Yamanaka, H., Kobayashi, K., Okubo, M. & Noguchi, K. Analgesic effect of gastrin-releasing peptide in the dorsal horn. There is a thing called mol. Pain 18, 17448069221108965 (2022).
Rižner, T. L. & Romano, A. Targeting the formation of estrogens for treatment of hormone dependent diseases–current status. Front. Pharmacol. 14, 1155558 (2023).
Source: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin
Loss of E-cadherin-mediated activation of ligand-dependent IGF1 receptor kinases in invasive lobular breast carcinoma
Hsiao, P.-W., Fryer, C.J., Trotter, K. W., Wang, W., and T.K. BAF60a are some of the authors. There’s a word that means “mol.” Cell. Biol. 23, 6210–6220 (2003).
M., Kadoch, C. and Chan, H.M. discussed the mechanisms and strategies associated with the Mammalian SWI/SNF. Trends Genet. 36, 928–950, will be implemented in 2020.
Elangovan, A. et al. Loss of E-cadherin induces IGF1R activation and reveals a targetable pathway in invasive lobular breast carcinoma. There’s a word for that. Cancer Res. 20 was published in 1992.
Qian, X., Karpova, T., Sheppard, A. M., McNally, J. & Lowy, D. R. E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J. 23, 1739–1748 (2004).
Morali, O. G. IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene 20, 4942–4950 (2001).
Source: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin
Measurement of estrogenic potential in waste water induced by DNA methylation – Induced E-cadherin silencing
Avberšek, M., Žegura, B., Filipič, M., Uranjek-Ževart, N. & Heath, E. Determination of estrogenic potential in waste water without sample extraction. J. Hazard. Mater. 260, 527–533 (2013).
M. Venza, et al. Clinicopathological features of melanoma are related to the activity of DNA methylation-Induced E-cadherin silencing. There is Oncol. Rep. 35 was voted on in the summer of 2016
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
Source: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin
Incidence and outcomes of pregnancy-associated cancer in women treated with high-dose oestrogen: a population-based linkage study
A. et al. The E-cadherin expression is suppressed by the Snail factor. Nat. Cell. 2, 76–83 (2000).
Lee, Y. Y. Incidence and outcomes of pregnancy-associated cancer in Australia, 1994–2008: a population-based linkage study. BJOG 119, 1572–1582 (2012).
Benyi, E. There are risks of cancer in women who are treated with high-dose oestrogen. It’s Horm. It is referred to as Res. The article was published in the journal Paediatr.
Source: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin
Metastasis of neoplastic tissue by N-RasQ61K-activated receptor: new perspectives and emerging mechanisms
Ackermann, J. et al. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res. 65, 4005–4011 (2005).
Some of the people who worked on the Lipid Metabolism in Cancer: new perspectives and emerging mechanisms are Broadfield and Pane. It’s the root of the word “dept.” Cell 56, 1363–1393 (2021).
Medes, G., Thomas, A. & Weinhouse, S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in tissue slices. The Cancer Res. 13 was published in1953.
Lang, X. et al. Radiotherapy and immunotherapy cause tumoral oxidation and ferroptosis. Cancer discov. 9, 1673–1694
Cai, Y. et al. Vitamin D suppresses ferroptosis and protects against neonatal hypoxic-ischemic encephalopathy by activating the Nrf2/HO-1 pathway. Transl. There is a Pediatr. 11, 1633–1644 (2022).
Source: Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis
Lipoproteomics: The role of docosahexaenoic acid in cancer cell growth and anti-cancer agent-based therapies
Hoofnagle, A. N. & Heinecke, J. W. Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins. J. Lipid Res. 50, 1967–1975 (2009).
Shah, R., Farmer, L. A., Zilka, O., Van Kessel, A. T. M. & Pratt, D. A. Beyond DPPH: use of fluorescence-enabled inhibited autoxidation to predict oxidative cell death rescue. There’s a drug called Cell Chem. The handbook of science, 26, 1595–1607.
Ou, W. et al. Low-density lipoprotein docosahexaenoic acid stimulates cell death in hepatocellular carcinoma. Free Radic. This is a summary of the work of the journal Biol. Med 112, 607 were published last year.
The glutamate/cystine antiporter can be used to improve cancer cell dependency onglucose. J. Biol. The Chem. 292, 14240, and 149 are published in the same year.
Asimakopoulou, A. P., Theocharis, A. D., Tzanakakis, G. N. & Karamanos, N. K. The biological role of chondroitin sulfate in cancer and chondroitin-based anticancer agents. In the book, In Vivo 22, 395–389.
A synthetic lethal screening identifies compounds that cause iron- dependent and nonapoptotic cell death in cancer cells. Chem. The article is titled, “Gale 15, 234–245.”
In this study, heparan sulfate is an enhancer of tumor growth and is also an anti-cancer agent. It was Proc. Natl Acad. Sci. USA 99, 568–573 (2002).
Source: Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis
Low density lipoproteins: role of SREBP aspartate cleavage-activating protein and cholesterol deprivation
Matsuda, M. et al. SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation. Genes Dev. 15, 1206–1216 (2001).
K., and her friends, wrote about their experience with Birsoy, et al. The aspartate synthesis can be achieved by using the important role of the mitochondrial electron transport chain. Cell 162, 540–551 (2015).
There is release of low density lipoprotein from its cell surface. Cell 7, 85– 95 was published in 1976.
Klaassen, C. D. & Boles, J. W. Sulfation and sulfotransferases 5: the importance of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J. 11, 409–423 in 1997.
Westley, J., Campbell, S. C., andSchwartz, N. B., took a picture of the -d xylosyltransferase that helps make chondroitin sulfate. The journal biochemistry 30, 7477–483 was published in 1991.
O. and other people are in this paper. There is a relationship between ferrostatin-1 and liproxstatin-1 and the role of oil in cell death. ACS Cent. Sci. 3, 232–243 (2017).
Source: Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis
A cellular matrix niche for Flk1+ hematoendothelial progenitors: High-density lipoprotein uptake protects tumours from ferroptosis
High-density lipoproteins are involved in reverse cholesterol transport and atherogenesis. Nat. Rev. Cardiol. 18, 712–723 (2021).
P., Hill, K.E., Burk, R. F., and Berry, M.J. J. Biol. Chem.289, 9195– 207.
Nandadasa, S. et al. The versican-hyaluronan complex provides an essential extracellular matrix niche for Flk1+ hematoendothelial progenitors. The Matrix Biol 97 was published in the year 2011.
Source: Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis
Effect of membrane fluidity on phospholipid order in a mouse model of benign prostate cancer: A systematic review and a peer-review
Harris, F. M., Best, K. B. & Bell, J. D. Use of laurdan fluorescence intensity and polarization to distinguish between changes in membrane fluidity and phospholipid order. Biochim. Biophys. Acta 1565, 123–128 (2002).
Bichod sulfate is deleted from breast tumors to promote metastasis. It’s called genes. Mol. Res. 10, 3901–3913 (2011).
Gatto, F. et al. The occurrence of clear cell cancer can be predicted by the level of conjugateglycan in the patients’ urine and blood. Cell Rep. 15, 1822–1836 (2016).
Klein, E. A. Vitamin E and the risk of prostate cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). The JAMA published a report on 1549–1556.
Source: Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis
Heparan sulfate proteoglycan-driven lipoprotein uptake protects cancer cells from ferroptosis
J. M. et al. were part of the project. Cholesterol clearance by triglycerides is determined by the presence of heparan sulfate proteoglycans. J. Clin. Invest. 117, 153–164 (2007).
Brandes, C. et al. The binding variant reelin is produced by alternative splicing in the ApoEreceptor-2’s binding domain. J. Biol. Chem 276, 22160–22516 was published in 2001.
Garcia-Bermudez, J. et al. Cancer cells are limited by aspartate limitation when stimulation of macropinocytosis is applied. The person is Nat. Metab. 4, 724–738 (2022).
Source: Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis
Study of ubiquinone in serum/plasma by high-performance liquid chromatography electrospray tandem mass spectrometry (ESI-LC-MS/MS)
Outcome of interaction of unilamellar liposomes with apolipoproteins. J. Lipid Res. 21, 993–1003 (1980).
Xue, J., Guijas, C., Benton, H. P., Warth, B. & Siuzdak, G. METLIN MS2 molecular standards database: a broad chemical and biological resource. Nat. Methods 17 was used for the year 2020.
De Leenheer, A. P., De Bevere, V. O., Cruyl, A. A. & Claeys, A. E. Determination of serum alpha-tocopherol (vitamin E) by high-performance liquid chromatography. The journal has a subsection on the subject of “Clan.” Chem. 24, 585–590 was published in 1978.
Mathieu, R. E. & Riley, C. P. Quantitation of ubiquinone (coenzyme Q10) in serum/plasma using liquid chromatography electrospray tandem mass spectrometry (ESI-LC-MS/MS). These methods are used in the fields of mol.bio. 1378, 61–69 (2016).
A. Basu and others. Quantitative HILIC-Q-TOF-MS analysis of glycosaminoglycans and non-reducing end carbohydrate biomarkers via glycan reductive isotopic labeling. Preprint at ChemRxiv https://doi.org/10.26434/chemrxiv-2025-60p82 (2025).
Source: Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis
Biomarkers of a mouse model with high barcode diversity for the analysis of genetic profiling in single cell population: A rationale-based approach
Li, L. et al. A mouse model with high barcode diversity for genetic profiling in single cells. Cell 186, 5183–5199 (2023).
Pavía-Jiménez, A., Tcheuyap, V. T. & Brugarolas, J. Establishing a human renal cell carcinoma tumorgraft platform for preclinical drug testing. Nat. Protoc. 9, 1848–1859 (2014).
The FAIR principles for the data of mass spectrometry were developed by GlycoPOST. Nucleic Acids Res. 49, D1523–D1528 (2021).